Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy

Biomedica

Volumn 32, Issue 2, 2012, Pages 182-188

  Chicaíza Becerra, Liliana Alejandra ^a   García Molina, Mario ^a   Gamboa, Óscar ^b  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Instituto Nacional de Cancerología   (Colombia)

Author keywords

Acute; Contrast media; Cost benefit analysis; Kidney tubular necrosis

Indexed keywords

CONTRAST MEDIUM; DRUG DERIVATIVE; IOBITRIDOL; IODIXANOL; IODOBENZOIC ACID DERIVATIVE; IOHEXOL; IOPAMIDOL; IOPENTOL; IOPROMIDE; IOXILAN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COLOMBIA; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION TREE; DRUG COST; ECONOMICS; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; OSMOLARITY; OUTPATIENT; PUBLIC HEALTH; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; RISK; STATISTICS; UTILIZATION REVIEW;

ACUTE KIDNEY INJURY; AGED; COLOMBIA; CONTRAST MEDIA; COST-BENEFIT ANALYSIS; DECISION TREES; DRUG COSTS; FEMALE; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; IOHEXOL; IOPAMIDOL; LENGTH OF STAY; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; OSMOLAR CONCENTRATION; OUTPATIENTS; RENAL DIALYSIS; RISK; TRIIODOBENZOIC ACIDS;

EID: 84869791902     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol. 2003;76:513-8.
2. Berg KJ. Nephrotoxicity related to contrast media. Scand J Urol Nephrol. 2000;34:317-22.
3. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259-64.
4. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930-6.
5. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology. 1993;188:171-8.
6. Taliercio CP, Vlietstra RE, Ilstrup DM, Burnett JC, Menke KK, Stensrud SL, et al. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J Am Coll Cardiol. 1991;17:384-90.
7. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491-9.
8. Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: A systematic review of angiographic contrast media in high risk patients. Kidney Int. 2005;68:2256-63.
9. a edición. Bogotá: Universidad Nacional de Colombia; 2010.
10. Nguyen SA, Suranyi P, Ravenel JG, Randall PK, Romano PB, Strom KA, et al. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: Effect on kidney function. Radiology. 2008;248:97-105.
11. Solomon R, Dumouchel W. Contrast media and nephropathy: Findings from systematic analysis and Food and Drug Administration reports of adverse effects. Invest Radiol. 2006;41:651-60.
12. From AM, Bartholmai BJ, Williams AW, Cha SS, McDonald FS. Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc. 2008;83:1095-100.
13. Klarenbach SW, Pannu N, Tonelli MA, Manns BJ. Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease. Crit Care Med. 2006;34:1044-51.
14. Caicedo MA. Nefropatía por medios de contraste. Acta Med Colomb. 2007;32:68-79.
15. Subramanian S, Tumlin J, Bapat B, Zyczynski T. Economic burden of contrast-induced nephropathy: Implications for prevention strategies. J Med Econ. 2007;10:119-34.
16. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006;295:2765-79.
17. Thomson VS, Narayanan K, Singh JC. Contrast induced nephropathy in urology. Indian J Urol. 2009;25:437-45.
18. Lee PT, Chou KJ, Fang HC. Preventing contrast-induced nephropathy in patients with baseline renal dysfunction undergoing coronary angiography. Curr Treat Options Cardiovasc Med. 2009;11:71-8.
19. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, et al. Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney Int. 1992;41:1274-9.
20. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995;47:254-61.
21. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Lundkvist J. Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy. Am Heart J. 2005;149:298-303.
22. Valls C, Andia E, Sánchez A, Moreno V. Selective use of low-osmolality contrast media in computed tomography. Eur Radiol. 2003;13:2000-5.
23. Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001;52:409-16.